Cosmos Pharmaceutical's Attributable Profit Jumps 25% in Fiscal H1

MT NewswiresJan 15 19:54 ET

Cosmos Pharmaceutical's Attributable Profit Jumps 25% in Fiscal H1; Shares Rise 6%

MT NewswiresJan 14 00:56 ET

COSMOS Pharmaceutical Reports Strong Growth and Strategic Stock Split

TipRanksJan 10 02:03 ET

Jefferies Adjusts Cosmos Pharmaceutical's Price Target to 8,300 Yen From 7,900 Yen, Keeps at Buy

MT NewswiresNov 12, 2024 02:08 ET · Ratings

Jefferies Keeps Their Buy Rating on COSMOS Pharmaceutical Corporation (3349)

TipRanksOct 14, 2024 08:19 ET · Ratings

COSMOS Pharmaceutical Posts Strong Q1 Growth

TipRanksOct 11, 2024 02:56 ET